✦ LIBER ✦

Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study

✍ Scribed by Fevery, J.; Elewaut, A.; Michielsen, P.; Nevens, F.; Van Eyken, P.; Adler, M.; Desmet, V.

Book ID: 123121274
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 548 KB
Volume: 11
Category: Article
ISSN: 0168-8278
DOI: 10.1016/0168-8278(90)90174-P

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of interferon alfa and lamivudi

Efficacy of interferon alfa and lamivudine combination therapy versus interferon alfa monotherapy in Turkish patients with chronic hepatitis B: A double-blind, randomized, comparative study

✍ Mehmet Cindoruk; Tarkan Karakan 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 561 KB

The preliminary results of the comparati

The preliminary results of the comparative efficacy of treatment with interferon alfa 2A and 2B in children with chronic hepatitis B

✍ I. Mozer-Lisewska; A. Kowala-Piaskowska; M. Figlerowicz; W. Służewski 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Interferon α-2b with and without ribavir

Interferon α-2b with and without ribavirin in the treatment of hepatitis B e antigen–positive chronic hepatitis B: A randomized study

✍ Chun-Jen Liu; Ming-Yang Lai; You-Chen Chao; Li-Ying Liao; Sien-Sing Yang; Tun-Je 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 1 views

To study whether interferon (IFN) ␣ and ribavirin combination therapy has a beneficial effect for hepatitis B e antigen (HBeAg)-positive chronic hepatitis B, we enrolled 119 such patients in a randomized study. Fifty-nine patients received 5 million units of IFN-␣2b daily for 4 weeks followed by 5 m

Daily or three times a week interferon a

Daily or three times a week interferon alfa2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C. Final results of a randomized prospective study

✍ V. de Ledinghen; P. Trimoulet; M. Winnock; J. Foucher; G. Chene; P. Couzigou; P. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Daily or three times a week interferon a

Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C

✍ Victor de Lédinghen; Pascale Trimoulet; Maria Winnock; Juliette Foucher; Marc Bo 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Efficacy and tolerability of peginterfer

Efficacy and tolerability of peginterferon alfa-2a or alfa-2b plus ribavirin in the daily routine treatment of patients with chronic hepatitis C in Germany: The PRACTICE Study

✍ T. Witthoeft; D. Hueppe; C. John; J. Goelz; R. Heyne; B. Moeller; G. Teuber; S. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB